Mid
M
MEDAI Stock Diagnostic Report
Medifast targets return to profitability in Q4 2026 as Trilivy rollout continues
[GROQ] Medifast aims to restore profitability in the fourth quarter of 2026, with continued expectations for revenue growth from the launch of Trilivy.
View Source Article ↗AI CATALYST SCORE80 / 100Score computed by Sentinel V12
REFERENCE PRICE$9.74Reference entry price at analysis time